Fidelity Disruptive Medicine ETF (FMED)Health | Exchange Traded Fund | NasdaqGM
30.64 USD
+0.06
(0.205%)
⇧
(Oct. 14, 2026, 4 p.m.
EDT)
|
Hot Take ↕ | Oct. 10, 2026, 10:22 a.m. EDT
The Fidelity Disruptive Medicine ETF presents a classic case of a niche thematic vehicle struggling with liquidity and market validation. While the recent headlines celebrate a 20.4% surge in June and a three-year milestone, the underlying data tells a different story regarding investor conviction. The trading volume is a fraction of the average, and the options market is entirely silent, suggesting that sophisticated capital is not actively betting on near-term moves. Furthermore, the valuation is steep at a trailing P/E of roughly 44.5, which is aggressive for an ETF unless the underlying portfolio companies are demonstrating explosive, sustainable growth that the market fully prices in. Without access to the price history to confirm if this recent rally is part of a robust multi-year trend or a temporary spike, the long-term outlook remains neutral; the business quality of the holdings cannot be verified against a multi-year track record. For now, this remains a speculative hold rather than a core investment, with no income component to offset the volatility. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.084524 |
| AutoARIMA | 0.086003 |
| AutoETS | 0.086292 |
| MSTL | 0.088179 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 47% |
| H-stat | 2.95 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.005 |
| Excess Kurtosis | 0.61 |
| Attribute | Value |
|---|---|
| Trailing P/E | 43.43 |
As of Oct. 10, 2026, 10:22 a.m. EDT: Options data is virtually non-existent for this instrument. There is zero open interest or volume recorded for either calls or puts across the available expiration dates, indicating a complete lack of speculative positioning or hedging activity by market participants.
| Date | Dividend | Yield % |
|---|---|---|
| 2024-12-20 | 0.112 | 0.447463 |
| 2024-06-21 | 0.001 | 0.004212 |
| Attribute | Value |
|---|---|
| All Time High | 32.985 |
| All Time Low | 19.88 |
| Ask | 28.87 |
| Ask Size | 1 |
| Average Daily Volume10 Day | 10,600 |
| Average Daily Volume3 Month | 6,603 |
| Average Volume | 6,603 |
| Average Volume10Days | 10,600 |
| Beta3 Year | 0.74 |
| Bid | 20.72 |
| Bid Size | 2 |
| Category | Health |
| Crypto Tradeable | 0 |
| Currency | USD |
| Custom Price Alert Confidence | HIGH |
| Day High | 30.78 |
| Day Low | 30.27 |
| Display Name | Disruptive Medicine ETF |
| Dividend Yield | 0.0 |
| Eps Trailing Twelve Months | 0.70557725 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 15 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 31.38196 |
| Fifty Day Average Change | -0.73916054 |
| Fifty Day Average Change Percent | -0.023553677 |
| Fifty Two Week Change Percent | 17.153168 |
| Fifty Two Week High | 32.985 |
| Fifty Two Week High Change | -2.3422012 |
| Fifty Two Week High Change Percent | -0.07100807 |
| Fifty Two Week Low | 23.48 |
| Fifty Two Week Low Change | 7.1628 |
| Fifty Two Week Low Change Percent | 0.3050596 |
| Fifty Two Week Range | 23.48 - 32.985 |
| First Trade Date Milliseconds | 1,686,576,600,000 |
| Five Year Average Return | 0.00252 |
| Full Exchange Name | NasdaqGM |
| Fullday Change | 0.10000038 |
| Fullday Change Percent | 0.32701236 |
| Fullday Price | 30.6428 |
| Fund Family | Fidelity Investments |
| Fund Inception Date | 1,586,995,200 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Has Pre Post Market Data | 1 |
| Ipo Expected Date | 2,023-06-12 |
| Language | en-US |
| Legal Type | Exchange Traded Fund |
| Long Business Summary | The fund normally invests at least 80% of assets in securities of disruptive medicine companies. Fidelity's disruptive strategies seek to identify innovative developments that could signal new directions for delivering products and services to customers. Generally, these companies have or are developing new or unconventional ways of doing business that could disrupt and displace incumbents over time. The fund is non-diversified. |
| Long Name | Fidelity Disruptive Medicine ETF |
| Market | us_market |
| Market State | POST |
| Max Age | 86,400 |
| Message Board Id | finmb_647865790 |
| Nav Price | 30.45141 |
| Net Assets | 52,309,348.0 |
| Net Expense Ratio | 0.5 |
| Open | 30.27 |
| Previous Close | 30.58 |
| Price Hint | 2 |
| Quote Source Name | Delayed Quote |
| Quote Type | ETF |
| Region | US |
| Regular Market Change | 0.062799454 |
| Regular Market Change Percent | 0.20536119 |
| Regular Market Day High | 30.78 |
| Regular Market Day Low | 30.27 |
| Regular Market Day Range | 30.27 - 30.78 |
| Regular Market Open | 30.27 |
| Regular Market Previous Close | 30.58 |
| Regular Market Price | 30.6428 |
| Regular Market Time | 1,792,008,000 |
| Regular Market Volume | 1,955 |
| Short Name | Fidelity Disruptive Medicine ET |
| Source Interval | 15 |
| Symbol | FMED |
| Three Year Average Return | 0.12955269 |
| Total Assets | 52,309,348 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing P E | 43.429405 |
| Trailing Peg Ratio | None |
| Trailing Three Month Nav Returns | 12.72538 |
| Trailing Three Month Returns | 12.72538 |
| Triggerable | 1 |
| Two Hundred Day Average | 27.4953 |
| Two Hundred Day Average Change | 3.147499 |
| Two Hundred Day Average Change Percent | 0.11447407 |
| Type Disp | ETF |
| Volume | 1,955 |
| Yield | 0.0 |
| Ytd Return | 18.89819 |